These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 28034876)

  • 21. miR-613 inhibits the growth and invasiveness of human hepatocellular carcinoma via targeting DCLK1.
    Wang W; Zhang H; Wang L; Zhang S; Tang M
    Biochem Biophys Res Commun; 2016 May; 473(4):987-992. PubMed ID: 27049311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of polymorphism in microRNA 604 with susceptibility to persistent hepatitis B virus infection and development of hepatocellular carcinoma.
    Cheong JY; Shin HD; Cho SW; Kim YJ
    J Korean Med Sci; 2014 Nov; 29(11):1523-7. PubMed ID: 25408584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A single nucleotide variant in microRNA-1269a promotes the occurrence and process of hepatocellular carcinoma by targeting to oncogenes SPATS2L and LRP6.
    Min P; Li W; Zeng D; Ma Y; Xu D; Zheng W; Tang F; Chen J; Shi J; Hu H; Wang J; Yang D; Liu J; Zhang J; Zhang M
    Bull Cancer; 2017 Apr; 104(4):311-320. PubMed ID: 28081866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long non-coding RNA 657 suppresses hepatocellular carcinoma cell growth by acting as a molecular sponge of miR-106a-5p to regulate PTEN expression.
    Hu B; Cai H; Zheng R; Yang S; Zhou Z; Tu J
    Int J Biochem Cell Biol; 2017 Nov; 92():34-42. PubMed ID: 28919047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-27b exerts an oncogenic function by targeting Fbxw7 in human hepatocellular carcinoma.
    Sun XF; Sun JP; Hou HT; Li K; Liu X; Ge QX
    Tumour Biol; 2016 Nov; 37(11):15325-15332. PubMed ID: 27704356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.
    Xu L; Beckebaum S; Iacob S; Wu G; Kaiser GM; Radtke A; Liu C; Kabar I; Schmidt HH; Zhang X; Lu M; Cicinnati VR
    J Hepatol; 2014 Mar; 60(3):590-8. PubMed ID: 24211739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-211 suppresses hepatocellular carcinoma by downregulating SATB2.
    Jiang G; Cui Y; Yu X; Wu Z; Ding G; Cao L
    Oncotarget; 2015 Apr; 6(11):9457-66. PubMed ID: 25888635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-34c-3p promotes cell proliferation and invasion in hepatocellular carcinoma by regulation of NCKAP1 expression.
    Xiao CZ; Wei W; Guo ZX; Zhang MY; Zhang YF; Wang JH; Shi M; Wang HY; Guo RP
    J Cancer Res Clin Oncol; 2017 Feb; 143(2):263-273. PubMed ID: 27704267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma.
    Fang F; Chang RM; Yu L; Lei X; Xiao S; Yang H; Yang LY
    J Hepatol; 2015 Oct; 63(4):874-85. PubMed ID: 25998163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MiR-425-5p promotes invasion and metastasis of hepatocellular carcinoma cells through SCAI-mediated dysregulation of multiple signaling pathways.
    Fang F; Song T; Zhang T; Cui Y; Zhang G; Xiong Q
    Oncotarget; 2017 May; 8(19):31745-31757. PubMed ID: 28423650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miR-345 inhibits tumor metastasis and EMT by targeting IRF1-mediated mTOR/STAT3/AKT pathway in hepatocellular carcinoma.
    Yu M; Xue H; Wang Y; Shen Q; Jiang Q; Zhang X; Li K; Jia M; Jia J; Xu J; Tian Y
    Int J Oncol; 2017 Mar; 50(3):975-983. PubMed ID: 28098858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of miR-149C>T and miR-499A>G polymorphisms with the risk of hepatocellular carcinoma in the Chinese population.
    Wang XH; Wang FR; Tang YF; Zou HZ; Zhao YQ
    Genet Mol Res; 2014 Jul; 13(3):5048-54. PubMed ID: 25061729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long non-coding RNA NEAT1 promotes hepatocellular carcinoma cell proliferation through the regulation of miR-129-5p-VCP-IκB.
    Fang L; Sun J; Pan Z; Song Y; Zhong L; Zhang Y; Liu Y; Zheng X; Huang P
    Am J Physiol Gastrointest Liver Physiol; 2017 Aug; 313(2):G150-G156. PubMed ID: 28526689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
    Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
    Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polymorphisms in the precursor microRNAs and aflatoxin B1-related hepatocellular carcinoma.
    Long XD; Huang XY; Yao JG; Liao P; Tang YJ; Ma Y; Xia Q
    Mol Carcinog; 2016 Jun; 55(6):1060-72. PubMed ID: 26152337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-10b exerts oncogenic activity in human hepatocellular carcinoma cells by targeting expression of CUB and sushi multiple domains 1 (CSMD1).
    Zhu Q; Gong L; Wang J; Tu Q; Yao L; Zhang JR; Han XJ; Zhu SJ; Wang SM; Li YH; Zhang W
    BMC Cancer; 2016 Oct; 16(1):806. PubMed ID: 27756250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-608 acts as a prognostic marker and inhibits the cell proliferation in hepatocellular carcinoma by macrophage migration inhibitory factor.
    Wang K; Liang Q; Wei L; Zhang W; Zhu P
    Tumour Biol; 2016 Mar; 37(3):3823-30. PubMed ID: 26474589
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MiR-155 and its functional variant rs767649 contribute to the susceptibility and survival of hepatocellular carcinoma.
    Ji J; Xu M; Tu J; Zhao Z; Gao J; Chen M; Song J; Zhu H; Cheng X; Hui J; Lan X; Yang X
    Oncotarget; 2016 Sep; 7(37):60303-60309. PubMed ID: 27531892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mir-765 promotes cell proliferation by downregulating INPP4B expression in human hepatocellular carcinoma.
    Xie BH; He X; Hua RX; Zhang B; Tan GS; Xiong SQ; Liu LS; Chen W; Yang JY; Wang XN; Li HP
    Cancer Biomark; 2016; 16(3):405-13. PubMed ID: 27062697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MiR-145 suppresses cell proliferation and motility by inhibiting ROCK1 in hepatocellular carcinoma.
    Ding W; Tan H; Zhao C; Li X; Li Z; Jiang C; Zhang Y; Wang L
    Tumour Biol; 2016 May; 37(5):6255-60. PubMed ID: 26615424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.